• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

nThrive Acquires Clinically Integrated Revenue Cycle Provider Adreima

by Fred Pennic 11/29/2016 Leave a Comment

nthrive

nThrive, an Alpharetta, GA-based provider of revenue cycle solutions has acquired Adreima, a Downers Grove, Ill.-based provider of patient-centered, clinically-integrated revenue cycle services that help patients find coverage and meet their financial obligations, while partnering with health care providers to optimize revenue cycle functions. Financial terms of the acquisition were not disclosed.

For nThrive, the acquisition strengthens it’s patient-to-payment roadmap that are essential to evolving industry dynamics, including patient eligibility determination and enrollment services, which improve the ability of health care providers to identify appropriate programs to fund care and assist patients in gaining access. Adreima’s capabilities also include strong programs supporting patient advocacy and self-pay collections. As patients take on a higher portion of financial responsibility for their care, providers increasingly seek to deliver a positive experience as patients work to resolve their financial responsibility.

nThrive’s technologies, revenue cycle services expertise, analytics depth and education services  enhance delivery of Adreima’s core offerings, building on its clinically integrated patient-centric approach. Once integrated, the combined offerings will deliver a better outsourcing cost-to-value proposition for providers and continue to build a pathway for providers to consolidate additional revenue cycle functions to a single supplier.

“We believe providers benefit from a single partner for their revenue cycle management, and we continue to invest in services and technology for our patient-to-payment spectrum of solutions that empower health care for everyone in every community,” says nThrive CEO Joel Hackney in a statement. “Our acquisition of Adreima’s patient-centered, clinically-integrated solutions demonstrates nThrive’s commitment to delivering on our promise to create greater innovation and scale that generates standardized and repeatable clinical, operational and financial performance for health care providers.”

Tagged With: Healthcare Mergers & Acquisitions, nThrive, Revenue Cycle Management, revenue cycle operations

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |